Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy

被引：2

作者：

Westin, Jason R. ^{[1
]}

Thompson, Michael A. ^{[2
]}

Cataldo, Vince D. ^{[3
]}

Toth, Bela B. ^{[4
]}

Sanjorjo, Perpetua ^{[5
]}

Bourgeois, Scott ^{[5
]}

Jimenez, Camilo ^{[6
]}

Murphy, William A. ^{[7
]}

Fanale, Michelle ^{[5
]}

Fayad, Luis ^{[5
]}

Fowler, Nathan ^{[5
]}

Kwak, Larry ^{[5
]}

McLaughlin, Peter ^{[5
]}

Neelapu, Sattva ^{[5
]}

Pro, Barbara ^{[5
]}

Rodriguez, Alma ^{[5
]}

Shah, Jatin ^{[5
]}

Hagemeister, Fredrick B. ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA

[2] Waukesha Mem Hosp, ProHlth Care Canc Ctr, Waukesha, WI USA

[3] Louisiana State Univ, New Orleans, LA USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Dent Oncol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2010年 / 10卷 / 03期

关键词：

D O I：

10.3816/CLML.2010.n.042

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E32 / E32

页数：1

共 50 条

[21] Irinotecan or etoposide as front-line therapy for SCLC?
Johnson, Faye M.
Glisson, Bonnie S.
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (10) : 562 - 563
[22] Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma
Cejalvo, Maria J.
de la Rubia, Javier
FUTURE ONCOLOGY, 2015, 11 (11) : 1643 - 1658
[23] Front-line therapy of advanced pancreatic cancer
Kindler, HL
SEMINARS IN ONCOLOGY, 2005, 32 (06) : S33 - S36
[24] Provider volume and guideline compliance in ovarian cancer patients receiving front-line chemotherapy
Aviki, E. M.
Roche, K. Long
Lavery, J. A.
Green, A. K.
Aghajanian, C. A.
Chi, D. S.
Leitao, M. M., Jr.
Sabbatini, P.
Bach, P. B.
GYNECOLOGIC ONCOLOGY, 2018, 149 : 149 - 149
[25] Irinotecan or etoposide as front-line therapy for SCLC?
Faye M. Johnson
Bonnie S. Glisson
Nature Reviews Clinical Oncology, 2009, 6 : 562 - 563
[26] Risk of Thromboembolism in Patients Receiving Immunotherapy-Based Combinations as Front-Line Therapy for Metastatic Renal Cell Carcinoma
Schuster, James
Sheng, Iris Y.
Reddy, Chandana A.
Khorana, Alok A.
Nizam, Amanda
Gupta, Shilpa
Gilligan, Timothy
Wee, Christopher E.
Sussman, Tamara A.
Bonham, Amanda
Maroli, Kimberly
Martin, Allison
Ornstein, Moshe C.
CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 92 - 97
[27] ACOPP chemotherapy for front-line treatment of older patients with Hodgkin lymphoma - a pilot study
Wilson, M.
Mckay, P.
Parsons, K.
Ogilvie, C.
Travers, J.
Martin, M.
Allan, J.
Osborne, W.
Leach, M.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 227 - 227
[28] Front-line management of diffuse large B cell lymphoma
Cabanillas, Fernando
CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) : 642 - 645
[29] OPHTHALMOLOGISTS ON FRONT-LINE IN TREATING AIDS PATIENTS
SPRINGER, M
ARCHIVES OF OPHTHALMOLOGY, 1987, 105 (03) : 325 - 325
[30] FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia
Kutsch, Nadine
Busch, Raymonde
Bahlo, Jasmin
Mayer, Jiri
Hensel, Manfred
Hopfinger, Georg
Hess, Georg
von Gruenhagen, Ulrich
Wendtner, Clemens-Martin
Fink, Anna Maria
Fischer, Kirsten
Hallek, Michael
Eichhorst, Barbara
LEUKEMIA & LYMPHOMA, 2017, 58 (02) : 399 - 407

← 1 2 3 4 5 →